Camurus Sustainability Profile
Camurus AB, a pioneering biopharmaceutical company headquartered in Sweden, focuses on developing innovative medicines for patients with severe and chronic conditions. Founded in 2016, Camurus has rapidly established itself in the pharmaceutical industry, particularly in the fields of pain management and addiction treatment. The company is renowned for its proprietary FluidCrystal® technology, which enables the formulation of long-acting injectable therapies. This unique approach enhances patient compliance and treatment outcomes. Camurus has achieved significant milestones, including the successful launch of its lead product, Buvidal®, for opioid dependence, positioning itself as a leader in the market. With a strong presence in Europe and expanding operations globally, Camurus continues to make strides in improving patient care through its advanced therapeutic solutions.
DitchCarbon Score
How does Camurus's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Camurus's score of 41 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Camurus's reported carbon emissions
In 2023, Camurus reported total carbon emissions of approximately 4,032,200 kg CO2e. This figure includes Scope 1 emissions of about 1,589,000 kg CO2e, Scope 2 emissions of approximately 17,480 kg CO2e, and Scope 3 emissions totalling around 3,856,000 kg CO2e. The previous year, 2022, saw total emissions of approximately 231,600 kg CO2e, with Scope 1 at about 162,400 kg CO2e, Scope 2 at approximately 8,990 kg CO2e, and Scope 3 at around 60,300 kg CO2e. Camurus has set a significant climate commitment, aiming to achieve carbon neutrality by 2040, specifically targeting Scope 1 emissions. This long-term goal reflects the company's dedication to reducing its carbon footprint and contributing to global climate efforts. The emissions data is sourced directly from Camurus AB (publ) and is not cascaded from any parent organization.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 162,400 | 0,000,000 |
| Scope 2 | 8,990 | 00,000 |
| Scope 3 | 60,300 | 0,000,000 |
How Carbon Intensive is Camurus's Industry?
How Carbon Intensive is Camurus's Location?
Camurus's Scope 3 Categories Breakdown
Camurus's Scope 3 emissions, which increased significantly last year and increased significantly since 2022, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 71% of total emissions under the GHG Protocol, with "Downstream Transportation & Distribution" being the largest emissions source at 7% of Scope 3 emissions.
Top Scope 3 Categories
Camurus's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Camurus has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.